Judit Sanz-Beltran

4PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Infectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1.

|Jun 25, 2026
Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review.

|Mar 01, 2026
Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial).

Aida Piedra, Albert Guinart-Cuadra, Sergio Martínez-Recio

|Oct 15, 2020
Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity.

Priscila Giavedoni, Sebastián Podlipnik, Juan M Pericàs

Pageof 1

Frequent Collaborators

2 joint publications

Maria Mulet

2 joint publications

Alberto Luis Moreno

2 joint publications

Jorgina Serra-López

2 joint publications

Rubén Osuna-Gómez